Apollo Hospitals Enterprise share news, announcements and annual reports
NSE: APOLLOHOSPBSE: 508869Healthcare ServicesLarge Cap
Apollo Hospitals Enterprise Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1983 on BSE, Jan 1996 on NSE
Last close ₹8,448.00up ₹248.00 (3.02%)BSE ₹8,400.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹8,200.00.
30 Oct: open ₹8,195.00, high ₹8,448.00, low ₹8,176.00
52-week range of traded prices to 30 Oct 2026
₹6,696.50Low, 23 Jan 2026₹9,070.50High, 23 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,21,469 Cr97th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 58.13
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 12.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 23.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,72,15658.2% delivered
Apollo Hospitals Enterprise share news and announcements
863 announcements, routine notices left out, newest first. Page 5 of 18.
Aug 2023
24 Aug · Legal
Exchange has sought clarification from Apollo Hospitals Enterprise Limited for the quarter ended 30-Jun-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.11 Aug · Results
11 Aug · Analysts
9 Aug · Analysts
Jul 2023
18 Jul · Updates
Jun 2023
May 2023
30 May · Management
30 May · Updates
30 May · Dividend
30 May · Corporate action
30 May · Dividend
30 May · Board meeting
30 May · Results
25 May · Analysts
Apr 2023
27 Apr · Updates
10 Apr · Updates
Feb 2023
16 Feb · Updates
16 Feb · Dividend
15 Feb · Results
14 Feb · Limited Review Report
14 Feb · Dividend
14 Feb · Corporate action
14 Feb · Updates
9 Feb · Board meeting
8 Feb · Analysts
4 Feb · Analysts
Jan 2023
Dec 2022
24 Dec
14 Dec · Communication to shareholders as per Reg 30
6 Dec · Communication to shareholders as per Reg 30
6 Dec · General updates
Nov 2022
30 Nov · Board meeting
26 Nov · Board meeting
23 Nov · Related Party Transaction